Noradrenaline: A circulating inhibitor of sodium transport

7Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.

Abstract

Leucocytes were isolated from venous blood of 11 normotensive volunteers with no family history of hypertension and the sodium efflux rate constants determined both alone and in the presence of increasing physiological concentrations of noradrenaline. There was a significant dose dependent reduction of total sodium efflux rate constant due to a reduction in ouabain sensitive sodium pump activity, glycoside insensitive efflux rate constants being unaffected. The magnitude of this effect was similar to the reduction in leucocyte sodium efflux rate constants observed in hypertensive patients (and their normotensive relatives). The noradrenaline induced depression of sodium pump activity was prevented by propranolol in a further seven experiments, suggesting that the effect was mediated by β adrenoceptors. Catecholamines possibly functioning as circulating inhibitors of sodium transport may contribute to some of the disturbances in membrane electrolyte handling both in essential hypertension in man and in some experimental models of hypertension.

Cite

CITATION STYLE

APA

Riozzi, A., Heagerty, A. M., Bing, R. F., Thurston, H., & Swales, J. D. (1984). Noradrenaline: A circulating inhibitor of sodium transport. British Medical Journal, 289(6451), 1025–1027. https://doi.org/10.1136/bmj.289.6451.1025

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free